A team of top equine vets is aiming to raise £125,000 for the Society for the Protection of Animals Abroad (SPANA) by travelling 3000 miles through Europe by motorbike between 22nd August and 9th September.
Sponsored by Elanco Animal Health, the seven-strong team is planning to travel through Belgium, the Netherlands, Germany, Switzerland, France, Italy, Morocco and Spain and deliver lectures to eight European and African veterinary schools in just two weeks.
Led by Professor Derek Knottenbelt from the University of Liverpool, the team also includes Professor Josh Slater from Royal Veterinary College, Dr John Burford from the University of Nottingham, Dr Caroline Hahn from the University of Edinburgh, Dr Michael Hewetson from the University of Helsinki, Ms Joanne Suthers from the University of Liverpool and Dr Edmund Hainisch from the University of Vienna. They are being supported by Jeremy Hulme, chief executive of SPANA, Nic Van Gelder, fundraising and supporter care administrator at SPANA and Cerian Stephens.
All money raised will provide SPANA with diagnostic and surgical equipment for the charity's veterinary clinics for working animals in Mali and Mauritania and for the further development of the Bamako Disabled Riding Centre in Mali.
Mike Brown, Elanco's UK and Ireland country director said: "We are delighted to be sponsoring the Vets with Horsepower European Tour which will raise vital funds for working animals in some of the world's poorest countries. This is just one of the many worthwhile initiatives we are supporting in 2012 which focus on alleviating world hunger, spearheading agricultural leadership, enhancing the human-animal bond and caring for the environment."
For further information on the Vets with Horsepower European Tour visit www.spana.org/horsepower.
Hysolv Animal Health has announced that it is offering a free swine flu laboratory diagnostic service to veterinary surgeons in the UK and Ireland.
The company will supply kits to veterinary surgeons with which to take samples from pig herds they suspect are infected with swine flu. The samples, nasal swabs or blood, will be sent direct to Germany where vaccine and biological company IDT Biologika is using a special facility to detect which viruses or antibodies against certain serotypes are present.
The virological tests will be conducted by the Institute for Virus Diagnostics, part of the Federal Research Institute for Animal Health. Antibody titres against H1N1, H1N2, H3N2, panH1N1 and panH1N2 will be looked for. Hysolv says these tests, including histopathology, can provide the only conclusive proof of influenza infection.
Results from the test — which would normally cost 230 Euros (about £185) to conduct — will be available within a week. IDT is believed to be the first company offering this type of test.
According to the company, the PCR test — from nasal swabs — is much more precise than previous testing regimes and will identify and type circulating strains as well as emerging strains.
Hysolv says that when swine flu strikes a farm, the signs seen are no longer just typically flu-like but a show whole range including fever, coughing, dyspnoea as well as returns to oestrus and abortions in sows. These may be in combination and concurrent with other diseases which makes accurate diagnosis difficult.
IDT will be offering the newly-branded vaccine Respiporc Flu 3 where the veterinary surgeon feels vaccination in indicated.
Hysolv director Richard Brealey said: “IDT is raising the bar in flu testing and this is a significant advance on what has been done in the past. In 2014 one-third of 1353 nasal swabs sent for testing proved positive for swine flu in Germany. In the UK the samples will help give an insight into the epidemiological status quo of the national pig herd.”
Allison Henry, product manager at Ceva Animal Health, said: "We have a very good relationship with the Royal Dick School of Veterinary Studies and it was an easy decision for us to support its students with this donation. Antimicrobial resistance is a very hot topic for human and animal health and as a manufacturer we have a duty to contribute as much as we can. Students are the next generation of veterinary surgeons and if we can educate them about antimicrobial resistance early on it will have a long term positive effect ensuring these products are used as rationally as possible and only when necessary."
Dr Tim Nuttall, head of dermatology at the Royal Dick School of Veterinary Studies, added: "We are very grateful to Ceva Animal Health for its generous support of our student research projects into antimicrobial resistance. These give our veterinary students an immensely valuable insight into the problems of antimicrobial resistance and helps them find novel approaches to counter this threat. This will not only benefit their careers but will also be of great value to vets, animals and owners throughout the world."
Ceva's efforts to support practices in their efforts to use antibiotics responsibly have continued in 2017 with the launch of GRAM (Guidance for the Rational use of AntiMicrobials), a guide on the rational use of antimicrobials in dogs and cats.
For more information on GRAM and sustainable antibiotic use, contact your local Ceva Animal Health territory manager.
Scandinavian Micro Biodevices (SMB) has launched its new diagnostic device: QuickVet Analyzer. The device brings novel ‘point of care’ testing to the clinic.
The QuickVet Analyzer and QuickVet COAG test cartridge provide analytical results in pets’ blood samples to help diagnose a range of conditions such as:
Investigating potential coagulation problems is an important pre-operative procedure.
SMB Chief Executive Officer, Mr Ole Kring, said: “The QuickVet Analyzer is simple to use, requires no routine maintenance and delivers results of high precision.”
The SMB device brings state of the art, ‘lab-on-a-chip’ concept from human diagnostics to the veterinary clinic, giving vets diagnostic test results in approximately ten minutes. Instead of waiting until the next day for the result, vets can offer pet owners an instant diagnosis.
The Quickvet Analyzer uses individual test cartridges based on microfluidic technology. The first test cartridge to be launched - the QuickVet COAG test - will analyse the intrinsic activated partial thromboplastin time (aPTT) and extrinsic partial thromboplastin time (PT) coagulation cascade from citrated whole blood in just minutes at an unmatched precision level of 7% CV in the relevant diagnostic range.
With touch screen operation, the instrument requires minimal training and is very user-friendly – the vet just adds a blood sample on the disposable cartridge and reads the result on the 7” colour screen.
The Quickvet COAG test is the first of several test cartridges being rolled out by SMB, which will be used in conjunction with the QuickVet Analyzer. They will all use whole blood samples and provide novel in-clinic diagnostic capabilities within the areas of infectious diseases, parasites and parasite transmitted diseases, toxicology, hormones, oncology and cardiology.
For further information on the QuickVet Analyser and QuickVet COAG test cartridges please contact:
Mr Ole Kring CEO Scandinavian Micro Biodevices ApS Gammelgaardsvej 87C DK-3520 Farum Denmark http://www.quickvet.net/ Telephone: +45 203 378 58
Graham Gardner has launched its summer collection of scrubwear in the form updated versions of its Urbane and Easiphit Collections, with new colour combinations added to the range.
The Urbane Collection, pictured right, is designed specifically for the female form. Easiephit is a contempary unisex collection.
Simon Ward, Sales Director said: "Scrubwear is becoming a firm favourite with veterinary staff in the UK. The relaxed comfort offered by scrubs is very attractive to staff, and the smart image of colour coded garments is very well received by managers seeking a unified department look. With the increased stocks and increased colour combinations, customers can now get their hands on the new uniforms more quickly than ever before!"
Other colour combinations are still available as special imports. Non-stocked colour requests will be directed to Grahame Gardner's USA Partners and the sales team will ensure that customers are kept updated as to delivery times.
Both Easiephitt and Urbane have also increased their stocked size range. Grahame Gardner now aim to hold sizes from extra, extra small to extra, extra large.
For further information on Urbane, Easiephitt or Grahame Gardner Ltd, please call 0116 255 6326, or visit http://www.grahamegardner.co.uk/.
Guillaume Fournié and Dr Javier Guitian from the Royal Veterinary College - working with colleagues from the London School of Hygiene and Tropical Medicine and Imperial College - have developed a model to understand how live bird markets act as a "hub" of infection for domestic poultry and if rest days, during which such markets are emptied and disinfected, may reduce transmission.
The results are published today in Interface - the Journal of The Royal Society. PhD student Guillaume Fournié, who led the research, said: "Live bird markets can be a reservoir of infection for domestic poultry and may therefore be responsible for sustaining H5N1 HPAI virus circulation.
"Compared to interventions applied in farms - such as stamping out and vaccination - our model shows that frequent rest days are an effective means with which to reduce H5N1 HPAI infection rates. Furthermore, our model predicts that full market closure - as has been implemented in some countries such as Egypt and Vietnam - would only be slightly more effective than rest days to reduce transmission of the disease."
The models used in the study are based on the live bird market chain in Hong Kong and the analysis restricted to chickens. Fournié, who qualified to be a vet in Alfort in his native France, was awarded fully-funded studentships (tuition fees and a living allowance) in 2007 by The Bloomsbury Colleges - a consortium of six colleges of the University of London: Birkbeck, IoE, LSHTM, RVC, School of Oriental and African Studies, and The School of Pharmacy - to conduct the research.
Since December 2003 outbreaks of H5N1 Highly Pathogenic Avian Influenza (HPA1) affecting domestic poultry have been reported in 50 countries across the world. Massive economic losses and the pandemic threat make H5N1 HPAI one of the greatest current public health concerns.
A full copy of the report can be seen in Interface at http://rsif.royalsocietypublishing.org
Cyclofin contains two active ingredients: 200 mg/ml of the anti-inflammatory flunixin-meglumine (eq. to 33.2 mg/ml flunixin meglumine) and 300 mg/ml of the class D anti-infective, oxytetracycline (eq. to 323.5 mg/ml oxytetracycline trihydrate).
Dechra says Cylofin acts within 24-36 hours and has sustained anti-bacterial activity for five to six days following a single intramuscular injection.
Administration is deep intramuscular injection in cattle and Cyclofin has a 35-day withdrawal period and a memorable dose rate of 1 ml per 10 kg body weight.
Alana McGlade MRCVS, national sales manager at Dechra, said: “BRD is one of the most prevalent and costly diseases on farm and early administration of an effective and fast-acting NSAID/antibiotic combination treatment, such as Cyclofin, can help relieve discomfort and stress, alleviate pain and improve demeanour and food intake.”
Cyclofin is available in 100ml vials.
https://www.dechra.co.uk/products/livestock/prescription/cyclofin#Cyclofin-300mg-ml.
The World Small Animal Veterinary Association (WSAVA) has launched its annual search for veterinary surgeons deserving of an award for significantly advancing the care of companion animals.
Nominations are invited for the following awards, which will be presented during the 2011 WSAVA World Congress which takes place in Jeju, Korea from October 14-17 2011.:
WSAVA Hill's Pet Mobility AwardTo recognise the outstanding work of a clinical researcher in the field of canine and feline orthopaedic medicine and surgery. Through improvements in the mobility and quality of life of pets, the research should have contributed significantly to the well-being of pets' lives and to the human-animal bond worldwide.
WSAVA Hill's Excellence in Veterinary Healthcare AwardTo recognise the outstanding work of a veterinary surgeon in promoting companion animal healthcare and the human-pet-veterinary bond through leading-edge clinical nutrition and through advanced medical and surgical techniques which enrich relationships between people and their pets.
WSAVA International Award for Scientific AchievementTo recognise the outstanding contribution of a veterinary surgeon who has furthered the advancement of knowledge of the cause, detection and management of disorders in companion animals.
Professor Jolle Kirpensteijn, President of the WSAVA, said: "Our prestigious awards recognise the achievement of members of the veterinary profession around the world as they continue to push the boundaries of veterinary care for companion animals. The standard of entries is always high, reflecting the ground-breaking research and work being carried out by our colleagues in many countries. We look forward to reviewing the nominations for the 2011 awards.
We are also grateful to Hill's Pet Nutrition for its generous sponsorship of these awards and for its continuing support of the WSAVA. The awards are just one of the ways in which we work to deliver on our joint vision to foster the development of veterinary knowledge on a global scale."
The WSAVA Executive Board also makes a special additional award for service to the profession. The award is designed to recognise exemplary service by a veterinary surgeon to foster and enhance the exchange of scientific and professional ideas throughout the world. For 2011, the award will be sponsored by Dr John Holt, a long-term supporter of the WSAVA, past president (1986-88) and Service to the Profession award winner (1998.)
Nominations for all awards can be sent to the WSAVA Secretariat by e-mail, fax, or post (http://www.wsava.org/Contact.htm ) and should include a covering letter, nominee CV and list of nominee publications. Nominations must be received by the WSAVA Secretariat by 15 November 2010.
Fifty young people from low and middle income backgrounds will have the opportunity to learn what it takes to become a vet and prepare to apply to a veterinary school, at a summer school run by the Sutton Trust and the Royal Veterinary College.
The RVC joins nine other UK universities in providing 1900 summer school places this year, helped by a three-year grant of £750,000 to the summer school programme from Barclays.
Each year, around 1,500 applicants apply for 664 places at the seven veterinary schools in the UK.
The 50 successful applicants to the RVC summer school this year will enter a week-long residential course with all expenses covered. The academic programme will focus on Bioveterinary Sciences, Veterinary Medicine and Veterinary Nursing taught by full-time academic staff. It will include practical dissections, clinical skills, farm-based sessions and laboratory periods. The participants will also be given sessions on the application process and interviews.
Sir Peter Lampl, chairman of the Sutton Trust and of the Education Endowment Foundation, said: "I'm delighted that the Royal Veterinary College has joined the Sutton Trust UK summer school programme. Veterinary courses are highly competitive, but it is vital that young people from low and middle income backgrounds have a fair chance to access them.
"Veterinary life is an attractive career choice for many bright young people, not just for the interest and variety of the work but also for the earning opportunities. The 50 students who enrol at the Royal Veterinary College this year will be given the best opportunity to prepare for university courses through our highly successful summer school model." Professor Stuart Reid, Principal at the Royal Veterinary College, said: "For many years the Royal Veterinary College has been focused on widening access to veterinary education to the most able students regardless of their background. The Sutton Trust has a long and successful tradition of supporting under-privileged students into higher education and we are proud to be working with the Trust's summer school programme.
"We hope that the summer school will demonstrate the broad range of exciting opportunities available to students with an interest in veterinary science and encourage more students from non-traditional backgrounds to consider a veterinary career."
Young people interested in applying to Sutton Trust summer schools can find more information at http://www.suttontrust.com/students/uk-summer-schools/
Sponsored by Vetoquinol UK, manufacturers of Cimalgex, the webinar will consider the reasons for switching medications and the pharmacological properties which affect the decision process.
The session aims to better equip vets to make a more informed decision that balances risk of side effects with achieving optimal patient pain management and welfare.
Duncan said: "NSAIDs remain a useful therapeutic tool for pain management in companion animals, particularly for conditions such as canine osteoarthritis.
"Although their benefits are clear at a group level, individual animal response can vary significantly; this is one of the key reasons why a clinician may switch a patient to a different NSAID, but due to concerns around adverse effects this often involves a washout period which can lead to gaps in pain management."
In the webinar, hosted on the WebinarVet platform, Duncan will give an overview of the ‘Whens, Whys and Hows’ of switching NSAIDs in dogs.
This will include findings from scientific studies and recommendations around switching safely, including when the washout period should be observed.
Vetoquinol UK has also put together a free guide for vets on the topic, authored by Dr Lascelles.
Felicity Holford MRCVS, vet and Product Manager at Vetoquinol UK, said: "Vets are prescribing NSAIDs every day, but the existing information around switching and washout periods is limited and can be difficult to apply in practice.
"The webinar and guide will go into the science around the topic and the poster is there to act as a handy prompt for day-to-day use."
Veterinary professionals can register their interest for the webinar here: https://bit.ly/Vetoquinol-WebinarVet
The free NSAID guide and clinic poster are available here: https://bit.ly/NSAID-guide-Vetoquinol
Vetoquinol has announced the winners of the 2008 Marbocyl Achievement Awards. Six veterinary schools took part in the award scheme, which enabled them to recognise the achievements of either staff or students, with a prize fund of £2000 for each university.
Five of the vet schools have announced their 2008 winners, the University of Liverpool will announce its winners in January 2009. Those who have already received their awards this year are:
University of Bristol Dr Catherine Fuller, MRCVSMs Kathryn Murphy, MRCVSMichael Steele, MRCVSChristopher Hudson, MRCVSSamantha Taylor, MRCVS
All of the winners are members of staff nominated by their students for excellence in teaching.
University College DublinDr Carmel Mooney, MVB MPhil PhD DECVIM-CA MRCVS, for an outstanding performance as Clinical Director of the Veterinary Hospital at UCD.
University of CambridgeAdrian Wallace, BVSc (Hons), MACVSc (SAS), MRCVS for his clinical research paper , ‘A biomechanical comparison of six double-loop configurations for use in the lateral fabella suture technique for the cranial cruciate ligament deficient canine stifle', Journal of Veterinary and Comparative Orthopaedics and Traumatology, 2008. Catherine Stalin, MA, VetMB, MRCVS for her paper ‘Radiographic morphology of the cranial portion of the cervical vertebral column in Cavalier King Charles Spaniels and its relationship to syringomyelia', American Journal of Veterinary Research, 2008 Penny Watson, MA, VetMB, CertVR, DSAM, Dip ECVIM, MRCVS, European Specialist in Small Animal Medicine for her clinical research paper ‘Prevalence and breed distribution of chronic pancreatitis at post-mortem examination in first opinion dogs' Journal of Small Animal Practice, 2007.
University of GlasgowMark Lowrie, MA VetMB MRCVS, for his Clinical Research Abstract - "Acute phase proteins and immunoglobulin A in steroid responsive meningitis-arteritis"
Royal (Dick) School of Veterinary Studies EdinburghLesa Longley, MA BVM&S Cert ZooMed MRCVS for an exceptionally high level of achievement during her residency programme.
Mark Leddy, Vetoquinol's Marketing Department Manager said: "We are delighted to have been able to help these universities recognise and reward the achievements of staff and students over the past three years."
The British Small Animal Veterinary Association has opened registration for next year's BSAVA / WSAVA / FECAVA Congress, offering the added incentive of some high value prizes for booking early.
Every month between now and December, everyone registered for the event will be entered into a draw. So if you book now, that gives you five chances to win:
In addition, booking early qualifies you for the Early Bird discount, and means you should secure any Masterclass and social tickets you might want.
You don't have to do anything other than register - either for yourself or for your practice - every person who pays for a registration between now and 29th December will go into the draw.
Peter Renwick, Partner, Willows Veterinary Centre said: "Given our involvement in professional development we are proud to sponsor one of the Big Booking Bonanza prizes - a complete set of the latest BSAVA Manuals that make a great addition to any interested small animal practitioner's bookshelf."
The BSAVA says that tor this WSAVA/FECAVA/BSAVA Congress there is a really broad and fascinating programme for 2012, with more for vets and nurses, plus a brilliantly expanded management programme and a new registration option for practice managers.
Visit www.bsava.com/congress for full details and terms and conditions.
The BSAVA has announced a partnership with the University of Liverpool to develop a national UK disease surveillance network for companion animals.
Originally established in 2008, the Small Animal Veterinary Surveillance Network, SAVSNET, aimed to monitor the disease status of the UK small animal population (mainly dog, cat and rabbit). However, funding for the project came to an end in August 2011. At this point, BSAVA stepped in with support, as it believed that not only would the profession benefit from this source of information, but that it is in fact vital for the successful management of disease in small animals.
BSAVA President Andrew Ash said: "SAVSNET ticks all the boxes for BSAVA. High quality large scale epidemiological research helps us fulfil our obligations as a charity to public good, the information on disease surveillance gives us the information to treat animals better, and the research papers help us inform veterinary policy and education. This is an important scheme for both animal and human health."
Participation by diagnostic labs and practices is voluntary, and all data gained will be made anonymous before being reported. For more information, email savsnet@liverpool.ac.uk.
A study carried out at the University of Leicester's School of Psychology has found that disagreeable younger people are more likely to prefer aggressive dogs, confirming the conventional wisdom that dogs match the personality of their owners.
Researchers found that low agreeableness was the best predictor of a preference for those dogs seen as more aggressive, such as bull terriers or boxers. Individuals low in agreeableness are typically less concerned with others' well-being and may be suspicious, unfriendly and competitive.
However, the study found no link between liking an aggressive dog and delinquent behaviour, or the possibility that liking an aggressive dog is an act of 'status display' to show off or attract romantic partners.
Dr Vincent Egan, lead researcher on the study, said: "This type of study is important, as it shows assumptions are not the whole picture. It is assumed owners of aggressive dogs (or dogs perceived as aggressive) are antisocial show-offs. But we did not find persons who expressed a preference for aggressive dogs had committed more delinquent acts, or reported showing off more.
"However, we did find a preference for a dog with an aggressive reputation was related to being younger and being lower in agreeableness (i.e., being less concerned with the needs of others, and being quicker to become hostile)."
The study looked at the reasons why some people prefer aggressive dog breeds. Professor Egan explained: "A lot of human behaviour involves status display and dominance, and evolutionarily this helps with finding mates. Basic personality also influences a lot of our behaviour. By measuring both at the same time, we could see whether they each had an influence on liking aggressive dogs, or whether one was due to another.
"We were surprised mating effort did not have an influence here, but think it might be because we looked at a wider age range. A preference for a non-aggressive dog may also make a statement about a person; liking a pedigree Labrador or a clipped Poodle may be as much a statement as having a pit-bull with a studded collar."
In the study, participants indicated their preference for different types of dogs, and filled in personality tests. The dogs were independently rated according to how aggressive people perceived them to be. Bull terriers were rated as most aggressive, followed by boxers; retrievers and cocker spaniels were seen as least aggressive.
Analysing the findings, the research team found that certain personality factors indicated a preference for dogs perceived to be more aggressive. Low agreeableness and higher conscientiousness were related to a preference for aggressive dog breeds. Younger people were also more likely to prefer the aggressive breeds.
Surprisingly, the results indicated a small effect suggesting that those who liked aggressive dogs showed signs of conscientiousness - being careful, reliable and thoughtful about their actions. This contradicts the perception that owners of aggressive dogs are always irresponsible.
Dr Egan said: "These results with conscientiousness were unexpected, but the effect is a small one, and needs to be repeated in a different group of people. Studies of this kind tend to only look at a restricted age ranges, which may exaggerate findings which do not occur across the entire lifespan, so we believe a stereotype is always true, whereas it may only be true under certain conditions. Our study employed a broader age range.
"We were surprised to find a small association between a preference for aggressive dogs and greater conscientiousness (i.e., valuing and following rules). However, dogs also prefer rules and firm boundaries themselves. We speculate that cheap dog-training classes would be enjoyable and beneficial for both dog and owner."
The findings were published last week in the journal Anthrozoos.
The British Small Animal Veterinary Association is using European Antibiotics Awareness Day (today) to highlight its guidance on the appropriate use of antimicrobials.
European Antibiotic Awareness Day is an annual campaign held to raise awareness of prudent antibiotic use and the threat of antibiotic resistance. While in the past it has focused on use of antibiotics in human healthcare, there is an increasing realisation that antimicrobial resistance is a 'One Health' issue with implications for human and animal health as well as the environment.
Professor Michael Day, BSAVA President said: "For both veterinary professionals and those working in human health, the spread of multi-drug resistant bacteria means that we may reach the point where we can no longer treat every day infections or diseases. So the responsible use of antimicrobials is an important focus for this pan-European campaign.
"Antibacterial resistance is now a politically important topic for our profession, and there are those who wish to restrict veterinary use of certain antibacterial products, which could have significant implications for animal health and welfare. It is therefore essential that veterinary surgeons are seen to be using antimicrobials responsibly."
Freda Andrews, the Director of Education at the RCVS, has announced her retirement from the position on 2nd April after nearly 16 years at the College.
Freda joined the RCVS as Head of Education in September 1999 and became Director of Education in 2013, with strategic responsibility for both veterinary and veterinary nursing education.
Nick Stace, RCVS Chief Executive Officer, said: "We will miss Freda for her professionalism, her encyclopaedic knowledge of all things related to veterinary education and her attention to detail, but she leaves behind a team that is stronger-than-ever and a considerable legacy for the profession as a whole.
"Under her watch the Education Department has seen a significant number of achievements. This includes the introduction of the Professional Development Phase which has helped veterinary graduates develop their confidence and competence during the first few years of practice and the accreditation of the University of Nottingham's School of Veterinary Medicine and Science - the first new UK vet school in 50 years."
Freda's responsibilities as Director of Education will now be split between Christine Warman, Head of Education, and Julie Dugmore, Head of Veterinary Nursing.
Freda said: "I have really enjoyed working with such a fascinating profession and I think that through working very closely with our colleagues in the vet schools, as well as with practising vets, veterinary education has made some significant advances. For example, there is more focus now on communication and professional skills and greater alignment of accreditation standards internationally, to name but two things.
"I am sad to leave but I know that the future of veterinary and veterinary nursing education has been left in the very safe hands of Christine and Julie and their respective teams."
The research will specifically focus on Mycoplasma hyopneumoniae (M.hyop), the causative agent of the disease, and aim to progress vaccine development.
Zoetis has stumped up another £300K in kind to support the research.
M.hyop is present in 80% of UK pig herds, which can result in a 16% reduction of growth and a 14% reduction in feed conversion in pigs.
This therefore, is not only a welfare issue for pigs but can significantly increase production costs for farmers.
Piglets are at particular risk of contracting the disease alongside secondary pathogens during lactation.
There are currently no commercial vaccines available that would prevent initial infection, and while M.hyop is susceptible to a variety of antibiotics, their use needs to be reduced to avoid overuse and the occurrence of multi-drug resistant strains.
The priority for the RVC researchers will therefore be developing new vaccines.
The team will also research the optimisation of protocols to eliminate M.hyop from pig herds in an effort to further minimise potential transmission.
Professor Dirk Werling, Professor of Molecular Immunology at the RVC, said: “Infection of Mycoplasma hyopneumoniae is a really debilitating disease in pigs that causes huge economic losses for farmers.
"I am very pleased that we will be able to continue working with a pharmaceutical partner to develop a new vaccine using state-of the-art technologies.”
CEVA Animal Health has added to its joint care range with the launch of Meloxidyl Injection to help control post-operative pain in cats and dogs and alleviate musculoskeletal pain in dogs.
CEVA says Meloxidyl Injection is bioequivalent to the leading meloxicam injection and dogs can be given Meloxidyl oral suspension 24 hours after Meloxidyl Injection has been administered.
Meloxidyl Injection is available in 10ml bottles containing 5mg/ml of meloxicam.
For further information, please contact your CEVA Animal Health representative or call 01494 781510.
Fiona Knight, a Customer Care Manager from the Woodcroft Veterinary Group in Cheshire, has won the 'Petplan Insurance Advisor Award 2011'.
The award, announced at the British Veterinary Nursing Congress in Kettering, recognises the hard work and dedication that Petplan Insurance Advisors do to highlight the importance of insurance to pet owners.
Fiona said: "It was such a shock to actually win the award, I'm very pleased!. All the finalists, including me, have worked incredibly hard to carry on promoting something we feel so strongly about. It's not something we can do on our own which is why I am so grateful for the dedication and support from my team at the practice.
"The Petplan PIA is such a great scheme as it helps increase the awareness of pet insurance, and really helps owners have financial security and their pets get the best treatment should anything happen."
The finalists were judged by Petplan Business Developers Lisa Allen and Spencer Jones.
Spencer said: "All three finalists have worked extremely hard to educate pet owners about pet insurance so that they are able to give their customers informed and up-to-date advice, however Fiona's commitment and dedication really stood out and she is a very deserving winner."
As part of her award Fiona receives a 16GB Ipad2 with WiFi, worth £399. The other finalists were Harriet Goulden, veterinary nurse at the Feldon Veterinary Centre in Leicestershire, and Alison Sawyer, receptionist at Medivet in Watford.
For information on how to become a PIA contact Vetline on 0800 316 8800 or alternatively log onto www.petplanpia.co.uk.
For the rankings, QS assessed 1496 programs across the world that offer courses in Veterinary Science, with the RVC placing second out of 427 institutions.
Professor Stuart Reid, Principal of the RVC, said: “Trading 1st and 2nd places with our friends at UC Davis globally, we are still very pleased to retain our ranking as highest placed veterinary school outside the USA.
"With a strong showing from schools in continental Europe and other newcomers to the top 10, the QS rankings emphasise once again the highly competitive nature of our subject internationally.
"We are pleased to record the highest score for academic reputation and an excellent performance in our research impact, and I congratulate Dean Lairmore - himself an honorary Fellow of the RVC - and his colleagues at UC Davis on regaining the top spot but serve notice that we will be seeking to trade again in 2021!”
Animalcare Marketing Manager, James Beaumont said: “Practice life is busier than ever and we know that practice teams are working very hard. It’s important that they are well-fuelled, so we aim to nourish their bodies and minds with our new Daxocox ‘Bitesize Lunch and Learns’. We’re simply asking practices to tell us their lunchtime desire and we’ll make sure that it’s delivered direct to their door.
"Then, in less time than it takes for them to demolish their feast, we’ll explain how breakthrough pain could be haunting their canine OA patients and, more importantly, how our new weekly NSAID, Daxocox, can help."
Practices can register for a lunch and learn and submit their lunch order by registering at www.daxocox.co.uk/lunch_learn or contacting Animalcare on 01904 487687.
Boehringer Ingelheim has released details of research presented at the 29th World Veterinary Congress which shows dogs with congestive heart failure (CHF) due to myxomatous mitral valve disease (MMVD) live longer when treated with pimobendan (Vetmedin®) compared with a commonly used ACE inhibitor.
The results of the QUEST trial, the largest international study of its kind to be conducted amongst dogs with congestive heart failure, are due to be published in the Journal of Veterinary Internal Medicine (JVIM) later this year.
The condition myxomatous mitral valve disease (MMVD) accounts for approximately 75% of all cases of CHF in dogs2. MMVD is associated with the thickening of the cusps of the mitral valve (one of the main one-way valves within the heart), affecting the flow of blood from the heart to the rest of the body. Although there is no cure for CHF due to MMVD, there are treatments available to manage the condition, improving the quality and length of the dog's life.
Professor Jens Häggström, lead investigator of the QUEST trial from the University of Uppsala, Sweden, commented that "the QUEST trial is a significant milestone in our efforts to reassure both, veterinarians and dog owners, that there is compelling evidence to show that pimobendan is an effective treatment for CHF that prolongs their dog's life and providing pet and owner with more quality time together."
The QUEST trial was a randomised, positive-controlled, multi-centre trial conducted at 28 sites across 11 countries, and is the largest study of its kind ever conducted in veterinary cardiology. The study compared a pimobendan group with a group treated with benazepril hydrochloride on top of background diuretic therapy. The trial spanned three years and followed dogs to death, euthanasia or treatment failure leading to withdrawal from the trial.
Research by Boehringer has also shown that over 50% of dog owners in the UK are unaware that their dog may be at risk of heart failure. Heart disease affects one in four dogs over seven years of age, and the lack of knowledge about this serious, life-threatening condition suggests that there is a need for better education amongst dog owners on how to recognise the disease, and how to maintain their dogs' heart health.
The RSPCA has reported that 11,586 animals were abandoned last year. That's more than 30 a day, and an increase of over 57% compared to the 7,347 animals that were abandoned in 2007.
Is this a precursor for tough times for the veterinary profession? Difficult to know. It conflicts with the record profits announced by CVS only a month ago. And perhaps the sort of people that would consider abandoning their animal under any circumstances are not likely to have been regular visitors to a vet in the first place.